Welcome
One Way Liver Genomics is a biotechnology company centered in the area of human health, with pioneering applications in the early diagnosis of liver disease.
To consolidate the developments of OWL Genomics as a technology-based company, an innovative line of development has been carried out, Metabolomics, which allows opening diagnostics to the massive identification of specific biomarkers for a given pathology. It is a technology that combines ultra performance liquid chromatography with mass spectrometry, with potential clients in hospitals, research centers, and biotechnology and pharmaceutical industries.
OWL Genomics has established a leading position in personalized medicine for liver disease, specifically, non-alcoholic steatohepatitis (NASH) and is currently introducing the first in vitro serum based diagnostic for Steatosis and NASH.
Company introduction